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Background and aims: Metabolic syndrome (MS) comprises a constellation of metabolic abnormalities 
associated with a high risk of developing diabetes and cardiovascular diseases. Central obesity, with 
related insulin resistance and inflammation are considered the core of the underlying pathogenesis of MS. 
Fibrinogen, an acute-phase reactant in the coagulation cascade, has been shown to play pivotal role in 
determining the extent of local or systemic inflammation. In this study, we examined whether plasma 
fibrinogen was predictive of incident MS in a community-based Chinese cohort. 
Materials and methods: Subjects were recruited from the Hong Kong Cardiovascular Risk Factors 
Prevalence Study (CRISPS) cohort. 2780 subjects were recruited in 1995-6 with baseline assessment 
performed. 1416 subjects without MS at baseline returned in 2005-8 for reassessment. MS was defined by 
ATP III criteria with waist circumference modified according to Asian cut-offs. 
Results: Of the 2780 subjects at baseline, 560(20.1%) had MS. Fibrinogen level correlated positively 
with age, fasting glucose, waist circumference, systolic and diastolic BP, and triglycerides and inversely 
with HDL (all p<0.001). Fibrinogen level increased with the number of components (0 to 5) of MS 
(p<0.01) and was significantly higher in subjects with MS (p<0.001). Of the 1416 patients without MS at 
baseline, 286(20.2%) developed MS in 2005-8 reassessment. Subjects who had incident MS, when 
compared with those without, were older (45.7±11.2 vs 42.1±11.8, p<0.01) and had higher fibrinogen 
level (2.53[2.20-2.93] vs 2.40[2.10-2.79], p=0.001) at baseline. There was no difference in gender or 
smoking status. On multivariate analysis, baseline fibrinogen remained to be an independent predictor for 
incident MS with age-adjusted HR 1.92 (1.03-3.55, p=0.039) per log unit increase in fibrinogen. 
Conclusion: Our findings confirmed plasma fibrinogen level, an indicator of inflammation, is an 
independent predictor of metabolic syndrome in this community-based Chinese cohort. 
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